Gene Expression Profiling for Acute Rejection in Lung Transplant Recipients
Author Information
Author(s): Liu Siqi, Westra Johanna, Hu Shixian, Verschuuren Erik A. M., van Kempen Léon C., van Baarle Debbie, Bos Nico A.
Primary Institution: University Medical Center Groningen
Hypothesis
Can gene expression profiling in PBMCs identify biomarkers for acute rejection in lung transplant recipients?
Conclusion
The study suggests that gene profiling of PBMC can help identify markers related to acute rejection in lung transplant recipients.
Supporting Evidence
- Distinct differential gene profiles were identified between patients with stable status and acute rejection.
- Significantly lower percentages of classical monocytes were observed in acute rejection patients.
- Validation of key genes was performed using qPCR, confirming their differential expression.
Takeaway
Researchers looked at blood samples from lung transplant patients to find clues about rejection. They found some important genes that could help doctors know when rejection is happening.
Methodology
The study used NanoString gene expression technology on PBMCs from lung transplant recipients to identify biomarkers for acute rejection.
Limitations
The study had a relatively small cohort size and not all samples were available at every time point.
Participant Demographics
Participants included 21 lung transplant recipients, with 13 experiencing acute rejection and 8 in stable condition.
Statistical Information
P-Value
p=0.0017 for CD68
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website